Jean-Francois Roux
Overview
Explore the profile of Jean-Francois Roux including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sapp J, Tang A, Parkash R, Stevenson W, Healey J, Gula L, et al.
N Engl J Med
. 2024 Nov;
392(8):737-747.
PMID: 39555820
Background: Patients with ventricular tachycardia and ischemic cardiomyopathy are at high risk for adverse outcomes. Catheter ablation is commonly used when antiarrhythmic drugs do not suppress ventricular tachycardia. Whether catheter...
2.
Camm A, Piccini J, Alings M, Dorian P, Gosselin G, Guertin M, et al.
Circ Arrhythm Electrophysiol
. 2023 Nov;
16(12):639-650.
PMID: 37950726
Background: Despite chronic therapies, atrial fibrillation (AF) leads to rapid ventricular rates (RVR) often requiring intravenous treatments. Etripamil is a fast-acting, calcium-channel blocker administered intranasally affecting the atrioventricular node within...
3.
Rivard L, Nault I, Krahn A, Daneault B, Roux J, Natarajan M, et al.
CJC Open
. 2023 Sep;
5(8):611-618.
PMID: 37720184
Patients with new-onset left bundle branch block (LBBB) after transcatheter aortic valve implantation (TAVI) are at risk of developing delayed high-degree atrioventricular block. Management of new-onset LBBB post-TAVI remains controversial....
4.
Atrial fibrillation progression after cryoablation vs. radiofrequency ablation: the CIRCA-DOSE trial
Andrade J, Deyell M, Khairy P, Champagne J, Leong-Sit P, Novak P, et al.
Eur Heart J
. 2023 Aug;
45(7):510-518.
PMID: 37624879
Background And Aims: Atrial fibrillation (AF) is a chronic progressive disorder. Persistent forms of AF are associated with increased rates of thromboembolism, heart failure, and death. Catheter ablation modifies the...
5.
Nair G, Birnie D, Nery P, Redpath C, Sarrazin J, Roux J, et al.
JAMA Cardiol
. 2023 Mar;
8(5):475-483.
PMID: 36947030
Importance: Recurrent atrial fibrillation (AF) commonly occurs after catheter ablation and is associated with patient morbidity and health care costs. Objective: To evaluate the superiority of an augmented double wide-area...
6.
Healey J, Krahn A, Bashir J, Amit G, Philippon F, McIntyre W, et al.
Ann Intern Med
. 2022 Nov;
175(12):1658-1665.
PMID: 36343346
Background: Implantable cardioverter defibrillators (ICDs) improve survival in patients at risk for cardiac arrest, but are associated with intravascular lead-related complications. The subcutaneous ICD (S-ICD), with no intravascular components, was...
7.
Andrade J, Deyell M, Macle L, Wells G, Bennett M, Essebag V, et al.
N Engl J Med
. 2022 Nov;
388(2):105-116.
PMID: 36342178
Background: Atrial fibrillation is a chronic, progressive disorder, and persistent forms of atrial fibrillation are associated with increased risks of thromboembolism and heart failure. Catheter ablation as initial therapy may...
8.
Nery P, Wells G, Verma A, Joza J, Nair G, Veenhuyzen G, et al.
Am Heart J
. 2022 Aug;
254:133-140.
PMID: 36030965
Background: Atrial low voltage area (LVA) catheter ablation has emerged as a promising strategy for ablation of persistent atrial fibrillation (AF). It is unclear if catheter ablation of atrial LVA...
9.
Andrade J, Macle L, Bennett M, Hawkins N, Essebag V, Champagne J, et al.
J Interv Card Electrophysiol
. 2022 Jun;
65(2):481-489.
PMID: 35739438
Background: Transseptal puncture to achieve left atrial access is necessary for many cardiac procedures, including atrial fibrillation ablation. More recently, there has been an increasing need for left atrial access...
10.
Parkash R, Wells G, Rouleau J, Talajic M, Essebag V, Skanes A, et al.
Circulation
. 2022 Mar;
145(23):1693-1704.
PMID: 35313733
Background: Atrial fibrillation (AF) and heart failure (HF) frequently coexist and can be challenging to treat. Pharmacologically based rhythm control of AF has not proven to be superior to rate...